Media Mosiac Gov Solutions Book a Strategy Call
Gov.MediaMosiac › GovCon News
🏛 GovCon Intel Opportunities Presolicitations Contract Awards Award Notices Grants Events Regulatory Search 📝 Insights
← Back to Federal Grants
FOR-FD-24-003

Utilizing Real-World Data and Algorithmic Analyses to Assess Post-Market Clinical Outcomes in Patients Switching Amongst Therapeutically Equivalent Complex Generic Drug Products and Reference Listed Drugs (U01) Clinical Trial Not Allowed

Federal Grant Forecasted Active
FOR-FD-24-003
Food and Drug Administration
Forecasted
$0
Active

📄 Description

Opportunity #: FOR-FD-24-003. Agency: Food and Drug Administration. Status: Forecasted Posted: 11/24/2023.
🔍 Search on Grants.gov → 🏛 View on SAM.gov (CFDA) More from this Agency
Program #: FOR-FD-24-003 • Added: Jul 14, 2026 11:47 AM

Program Info

$0
Total Funding
CFDA #FOR-FD-24-003
TypeForecasted
StatusActive

Related Programs

NARMS Cooperative Agreement Program to Strengthen Antibioti…
FOR-FD-25-014 • $0
Vet-LIRN Capacity-Building Project and Equipment Grants (U1…
PAR-23-202 • $0
Data Standards for Tobacco Research and Scientific Review P…
FOR-FD-23-027 • $0
Retail Food Safety Regulatory Association Collaboration
RFA-FD-26-003 • $0
🎯 Get GovCon Intel Free →